For example, it is unclear which symptoms can be ascribed to post-vaccine syndrome, how long these symptoms have to persist before patients can be suspected to have the syndrome, and how it can be distinguished from long COVID in the light of the high rate of past SARS-CoV-2 infections. At present, there is no recognised standard definition of post-vaccine syndrome. Swissmedic treats reports of such cases very seriously and continually reviews the latest drug safety findings and medical science literature. The symptoms reported, which may result in significant impairment for some of the individuals affected, cover a broad spectrum and overlap in some cases with long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). In the context of COVID-19 vaccinations, certain highly heterogeneous and generally prolonged symptoms that have occurred in vaccinated individuals with a temporal relationship to vaccination are also referred to as “post-vaccine syndrome”. Information from Swissmedic on individual safety aspects Post-vaccine syndrome However, the Agency will continue to monitor COVID-19 vaccines closely and new information on risks and safety signals will be communicated via the usual channels (website, DHPCs). The vaccines authorised in Switzerland reliably reduce the risk of contracting severe COVID-19.įor some time now, Swissmedic has been receiving far fewer reports of suspected adverse reactions than when vaccination first started and will therefore provisionally cease publishing regular updates on reported adverse reactions to COVID-19 vaccines in their current form. Thanks to the widespread use of COVID-19 vaccines, it is possible to continually gather up-to-date and comprehensive data on the risk-benefit ratio and include information on as-yet unknown rare side effects in the medicinal product information.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |